通过环介导恒温扩增鉴定疟原虫品种
|
By LabMedica International staff writers Posted on 01 Aug 2018 |
|
图片：在环烯烃共聚物(COC)板上用感染疟原虫的红细胞做原位LAMP的方案原理图（图片蒙日本国立产业技术综合研究所惠赐）。
疟疾是有不同种类的疟原虫引起的一种传染病，据报道其中五种会感染人类。因为恶性疟原虫引起的疟疾最严重，致死率高，所以准确及时的诊断对于有效管理至关重要。
当前诊断疟疾的金标准是用显微镜检查吉姆萨染色的血液涂片。因为鉴定疟原虫品种是由显微镜医师人工搜寻感染了疟原虫的红细胞，所以寄生虫血症不严重或混合感染的情况常见人为误差导致的误诊。
日本国立产业技术综合研究所(www.aist.go.jp)的科学家在经过亲水处理的微孔板上对受感染的红细胞(iRBC)执行原位环介导恒温扩增(LAMP)，以在一块玻片上分析尽可能多的iRBC。用原位LAMP测定在细胞水平上鉴定疟原虫能被完成。科研小组使用了来自健康O型血献血者的新鲜红细胞，他感染了恶性疟原虫，其中60%处于环状期，超过20%处于滋养体期，不到20%处于裂殖体期。
将红细胞悬液——包括培养的恶性疟原虫、3D7株、被感染的红细胞——摊在环烯烃共聚物(COC)板表面，事先用日本东京莎姆克股份有限公司(www.samcointl.com)的SAMCO RIE系统（经过亲水处理）对表面做反应离子刻蚀处理，使之变得亲水，再搁置10分钟，让红细胞沉积在板表面。用RPMI 1640培养基洗板，它是几乎在整个板表面上形成的单层红细胞。然后用吹风机把板吹干。用福尔马林固定红细胞，继而用Triton X-100进行透化。然后，用地高辛(DIG)标记的dUTP和一组特异引物进行LAMP反应，扩增恶性疟原虫的18S rRNA基因。用荧光显微镜检可以检测到荧光阳性细胞，它们带有结合荧光素的抗DIG抗体，这样的细胞即为被感染的红细胞。
该研究的论文发表于2018年6月19日的《疟疾杂志》(Malaria Journal)。作者总结说，他们的研究显示，用原位LAMP在经过亲水处理的COC板上在单细胞水平鉴定疟原虫品种，可以极其灵敏、准确地诊断疟疾。上述成果将增强金标准方法诊断疟疾的效果。
日本国立产业技术综合研究所>>> www.aist.go.jp
莎姆克股份有限公司>>> www.samcointl.com
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Gold Member
Hybrid Pipette
SWITCH
Latest 微生物学 News
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read more
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
Pathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
Technology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read more
Aptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more